The majority of MF/MC and unifocal tumours were invasive ductal carcinomas (86.5 and 96.2% respectively), grade III (73.6 and 63.5% respectively), and HER2‐negative (75.0 and 73.6% respectively). Here, ERBB2 is linked to invasive ductal breast carcinoma.